Darzalex CAS 945721-28-8 Daratumumab

Model: MOS-new7
Place of Origin: Zhejiang,China (Mainland)
Name: Darzalex
Name 1: Daratumumab
CAS: 945721-28-8


skype basketAdd to Basket  Edit

Share |

Product Description

Payment & Shipping Terms Supply Capacity
Trade Term:FOB,CIF,DDPProduction Capacity:1kg/year
Payment Terms:T/T, WUPacking:according to the...
Min. Order:1 GramDelivery Date:7 days
Means of Transport:Ocean, Air, Land


CAS 945721-28-8

On November 16, 2015, the us FDA approved the release of Daratumumab, a new monoclonal antibody drug made by Janssen and marketed under the trade name Darzalex. Clinical use of multiple myeloma after treatment with protease inhibitors and immunosuppressive agents. The bioengineered drug is an anti-cd38 monoclonal antibody that targets a transmembrane extracellular enzyme CD38 molecule highly expressed on the surface of multiple myeloma cells and can induce rapid death of tumor cells through a variety of mechanisms. Because healthy cells and all myeloma cells express CD38, adequate evaluation of drug toxicity and therapeutic efficacy is required.

We can customize according to customer's requirement

if you have any question pls mail us or call us

Category: Hot anti-cancer medicines

Related Category: Pharmaceutical Intermediates  Customized Pharmaceutical API  Other Pharmaceutical API  Veterinary Medicine API  Diagnostic Agents API 

Offline Showroom in USA
QR Code